Caprotec Bioanalytics and Bayer sign research agreement

Published online: Aug 10, 2013
Viewed 967 time(s)

Caprotec Bioanalytics GmbH and Bayer CropScience announced that they have entered a second research collaboration to identify and elucidate a tractable agrochemical target using Caprotec's proprietary Capture Compound Mass Spectrometry technology (CCMS).

"We have decided to progress a second target with the team at Caprotec and benefit from the close working relationships established over the last two years," commented Markus Dollinger, Ph.D., head of pest control research at Bayer CropScience.

Building on the achievements of their initial collaborative project announced in December 2011, scientists at Caprotec and Bayer CropScience will work together employing Caprotec's unique CCMS technology platform to support the elucidation of another novel target. As part of the collaboration, Caprotec will profile the interactions of Bayer CropScience compounds with the proteome in relevant biological systems. Financial terms were not disclosed.

"We are pleased that Bayer CropScience has been able to experience the utility of our validated CCMS technology in the field of agrochemicals and we are very much looking forward to the continuation of our fruitful collaboration," said Jonathan Turner, Ph.D., CEO of Caprotec. "Our CCMS enabling technology has unique potential in supporting challenging compound discovery and development programmes in the wider life science industry."